-
51.
公开(公告)号:EA004254B1
公开(公告)日:2004-02-26
申请号:EA200101230
申请日:2001-12-21
Applicant: SERVIER LAB
Inventor: DE NANTEUIL GUILLAUME , BENOIST ALAIN , PASTOUREAU PHILIPPE , SABATINI MASSIMO , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON
IPC: C07D491/048 , A61K31/4433 , A61K31/444 , A61K31/541 , A61P9/10 , A61P19/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D405/14 , C07D417/14 , C07D491/04 , A61K31/443 , A61K31/4355
Abstract: Соединенияформулы (I)вкоторой Rпредставляетсобойатомводорода, атомгалогена, алкильнуюгруппуилиалкоксигруппу, Хпредставляетсобойатомкислорода, атомсерыилигруппу NR, вкоторой R представляетсобойатомводородаилиалкильнуюгруппу, Апредставляетсобойлюбуюизгрупп, описанныхв описании, ихизомеры, иихаддитивныесолис фармацевтическиприемлемойкислотойилиоснованием. Лекарственныепрепараты.
-
公开(公告)号:ES2198863T3
公开(公告)日:2004-02-01
申请号:ES99402016
申请日:1999-08-09
Applicant: SERVIER LAB
Inventor: HANESSIAN STEPHEN , ATASSI GHANEM , TUCKER GORDON , CAIGNARD DANIEL-HENRI , RENARD PIERRE
IPC: A61K31/18 , A61K31/185 , C12N9/99 , A61K31/35 , A61K31/351 , A61K31/4406 , A61K31/4418 , A61K31/445 , A61P43/00 , C07C319/14 , C07C319/20 , C07C323/60 , C07D211/20 , C07D213/34 , C07D309/04
Abstract: Hydroxamic acid derivatives (I) are new. Hydroxamic acid derivatives of formula (I) and their acid and base addition salts are new. R1 = 1-6C alkyl (optionally substituted by at least one OH, halo, 1-6C alkoxy, mercapto, 1-6C alkylthio, aryl, 1-6C acyl or amino (optionally substituted by one or two 1-6C alkyl, cycloalkyl or aryl)), 1-6C acyl, cycloalkyl, aryl, heterocyclic group or aminocarbonyl-1-6C alkyl (with amino optionally substituted by one 1-6C alkyl (optionally substituted by at least one aryl, 1-6C arylalkyl, cycloalkyl or 1-6C alkylaminocarbonyl; R2 = 1-4C alkylene; R3 = X or T-U'-V'- X = 1-6C alkyl, 1-6C acyl, 1-6C alkoxycarbonyl, 1-6C aminoalkyl (amino optionally substituted by one or two 1-6C alkyl), 1-6C hydroxyalkyl, 1-6C carboxyalkyl, 1-6C aminocarbonylalkyl, 1-6C mercaptoalkyl, cycloalkyl, aryl or heterocyclic; T = aryl or heterocyclic; U' = single bond, S, O, NH, carbonyl, -R8O-, -R8S-, -R8NH-, -R8OR9-, -R8-NH-R9-, -R8-CO-R9- or -R9- (with R8 bound to T and R9 bound to V'); R8 = 1-6C alkylene; R9 = arylene or heteroarylene; V' = 1-6C alkylene; R4 = biaryl, arylheteroaryl, heteroarylaryl, 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic; and provided that R4 is 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic, when R3 is T-U'-V'-. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:NO20031219A
公开(公告)日:2003-09-19
申请号:NO20031219
申请日:2003-03-17
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , DHAINAUT ALAIN , TIZOT ANDRE , FAUCHERE JEAN-LUC , KUCHARCZYK NATHALIE , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , KRAUS-BERTHIER LAURENCE
IPC: C07D401/06 , A61K31/517 , A61P9/00 , A61P25/00 , A61P35/00 , C07D401/14 , C07D403/06 , C07D407/14 , C07D409/14 , C07D521/00
CPC classification number: C07D231/12 , C07D233/56 , C07D249/08 , C07D403/06
-
公开(公告)号:FR2837201A1
公开(公告)日:2003-09-19
申请号:FR0203299
申请日:2002-03-18
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , DHAINAUT ALAIN , TIZOT ANDRE , FAUCHERE JEAN LUC , KUCHARCZYK NATHALIE , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , KRAUS BERTHIER LAURENCE
IPC: C07D401/06 , A61K31/517 , A61P9/00 , A61P25/00 , A61P35/00 , C07D401/14 , C07D403/06 , C07D407/14 , C07D409/14 , C07D521/00 , C07D403/14
Abstract: Quinazoline derivatives (I) are new. Quinazoline derivatives of formula (I), their enantiomers, diastereomers and salts are new. A = bond, 1-6C alkylene, 2-6C alkenylene, 2-6C alkynylene, T, A1-T, T-A1, A1-T-A1, or A1-T-A'1-T'; T, T' = carbonyl, carbonyloxy, thio, sulfirylsulfonyl, oxy, amino, 1-6C aminoalkyl, aminoaryl, carbonylamino, carbonylamino-1-6C alkyl, carbonylaminoaryl, oxycarbonyl, aminocarbonyl, 1-6C aminoalkylcarbonyl, aminoarylcarbonyl, sulfonylamino, sulfonylamino-1-6C alkyl, sulfonylaminoaryl, aminosulfonyl, amino-1-6C alkylsulfonyl or aminoarylsulfonyl; A1, A'1 = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; B = 1-6C alkyl, aryl, 3-10C cycloalkyl, Het1, Het2, arylaminoaryl or aryl-1-6C alkylaryl (all optionally substituted by 1-3 Z); D = 1-6C alkylene (where 1 C atom may be substituted by B); X = O or S; Z, R1 = halo, 1-6C alkyl, 1-6C alkoxy, OH, SH, CN, NO2, NH2, 1-6C alkylamino, di-1-6C alkylamino, 1-4C perhaloalkyl, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl, 1-6C alkylaminocarbonyl, di-1-6C alkylaminocarbonyl, carbamoyl or 1-6C alkoxycarbonylamino; R2 = H, or 1-6C alkyl, aryl, 3-10C cycloalkyl, Het1, Het2, aryl-1-6C alkyl or Het2-1-6C alkyl-3-10C cycloalkyl-1-6C alkyl or Het1-1-6C alkyl (all optionally substituted by halo, 1-6C alkyl, 1-6C alkoxy, OH, SH, CN, NO2, NH2, 1-6C alkylamino, di-1-6C alkylamino, 1-4C perhaloalkyl, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl, 1-6C alkylaminocarbonyl, di-1-6C alkylaminocarbonyl, carbamoyl, 1-6C alkoxycarbonylamino, or aryl-1-6C alkyl or arylamino (both optionally substituted by 1-3 Z)); aryl = phenyl, naphthyl or biphenyl; Het1 = 5-7 membered saturated or partially unsaturated mono- or polycyclic heterocycloalkyl containing 1-3 N, O or S atoms; Het2 = 5-11 membered mono- or bicyclic aromatic ring containing 1-3 N, O or S; m = 0-4; and n = 0-3; provided that when the 2 N atoms of the imidazol ring are substituted, the imidazole moiety becomes a cationic imidazolium moiety. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:CA2423259A1
公开(公告)日:2003-09-18
申请号:CA2423259
申请日:2003-03-18
Applicant: SERVIER LAB
Inventor: DHAINAUT ALAIN , GOLDSTEIN SOLO , FAUCHERE JEAN-LUC , TUCKER GORDON , TIZOT ANDRE , KUCHARCZYK NATHALIE , HICKMAN JOHN , PIERRE ALAIN , KRAUS-BERTHIER LAURENCE
IPC: C07D401/06 , A61K31/517 , A61P9/00 , A61P25/00 , A61P35/00 , C07D401/14 , C07D403/06 , C07D407/14 , C07D409/14 , C07D521/00 , C07D403/10
Abstract: Composés de formule (I): (voir formule I) dans laquelle A, B, D, x, R1, R2, m et n sont tels que définis dans la description, leurs stéréoisomères ainsi que leurs sels d'addition à un acide ou à une base pharmaceutiquement acceptable. Médicaments.
-
公开(公告)号:FR2821842B1
公开(公告)日:2003-05-09
申请号:FR0103068
申请日:2001-03-07
Applicant: SERVIER LAB
Inventor: DE NANTEUIL GUILLAUME , BENOIST ALAIN , LEFOULON FRANCOIS , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , BRIDON DOMINIQUE , EZRIN ALAN , HOLMES DARREN , HUANG XICAI
IPC: A61P35/00 , C07D471/04 , A61K31/437 , A61K31/4375 , C07D471/14
-
57.
公开(公告)号:SK12702002A3
公开(公告)日:2003-03-04
申请号:SK12702002
申请日:2001-03-06
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , PERRON-SIERRA FRANCOISE , ATASSI GHANEM , TUCKER GORDON , SAINT-DIZIER DOMINIQUE
IPC: A61K31/4164 , A61K31/4168 , A61K31/417 , A61K31/4184 , A61K31/426 , A61K31/4375 , A61K31/44 , A61K31/4402 , A61K31/505 , A61K31/55 , A61P9/00 , C07D233/24 , A61P19/10 , A61P27/02 , A61P29/00 , A61P33/14 , A61P35/00 , A61P43/00 , C07D213/36 , C07D213/74 , C07D223/04 , C07D223/12 , C07D233/48 , C07D233/54 , C07D235/10 , C07D235/14 , C07D235/30 , C07D239/14 , C07D277/18 , C07D277/20 , C07D277/42 , C07D401/12 , C07D403/12 , C07D471/04
Abstract: Compounds of formula (1):wherein:G represents an optionally substituted phenyl or optionally substituted heterocycle, G1 and G2 being N or C,T1 represents -CH2-CH2-, -CH=CH- or =CH-CH2-, and T2 is a bond, or T1 represents -CH2- or =CH- and T2 is -CH2-, =CH-,R5 represents -(CH2)m-COOR6,R6 and R6' represent hydrogen, alkyl, optionally substituted aryl or optionally substituted arylalkyl,A represents -CO-, -CH2-, =CH- or -CH= and W represents -CH-, =C- or -C=, or A represents -CO- or -CH2- and W represents N,X represents -CO-X1-, -CO-NR6-X1-, -NR6-CO-X1-, -O-X1-, -SO2-NR6-X1- or -S(O)n-X1-,Y represents -Y1-, -Y2-Y1- or -Y1-Y2-Y1-, Y1 being an alkylene, alkenylene or alkynylene, and Y2 being an arylene, heteroarylene, cycloalkylene or heterocycloalkylene,Z represents -Z1-, -Z10-NR6-, and -Z10-NR6-CO-, Z1 being a heteroaryl, heterocycloalkyl, heteroarylalkyl, heterocycloalkylalkyl, fused arylheteroaryl, fused arylheterocycloalkyl, fused heteroarylheterocycloalkyl, fused heterocycloalkylheteroaryl or fused heteroarylheteroaryl, each of which is optionally substituted, or a group,Z2-NR6 or Z2-NR6-CO, Z2 being a group Z1, alkyl or heteroalkyl, andZ10 represents Z1 or an alkyl,its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base,and medicinal products containing the same which are useful as vitronectin receptor antagonists.
-
公开(公告)号:NO20024275D0
公开(公告)日:2002-09-06
申请号:NO20024275
申请日:2002-09-06
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , PERRON-SIERRA FRANCOISE , ATASSI GHANEM , TUCKER GORDON , SAINT-DIZIER DOMINIQUE
IPC: A61K31/4164 , C07D233/24 , A61K31/4168 , A61K31/417 , A61K31/4184 , A61K31/426 , A61K31/4375 , A61K31/44 , A61K31/4402 , A61K31/505 , A61K31/55 , A61P9/00 , A61P19/10 , A61P27/02 , A61P29/00 , A61P33/14 , A61P35/00 , A61P43/00 , C07D213/36 , C07D213/74 , C07D223/04 , C07D223/12 , C07D233/48 , C07D233/54 , C07D235/10 , C07D235/14 , C07D235/30 , C07D239/14 , C07D277/18 , C07D277/20 , C07D277/42 , C07D401/12 , C07D403/12 , C07D471/04 , C07D
Abstract: Compounds of formula (1):wherein:G represents an optionally substituted phenyl or optionally substituted heterocycle, G1 and G2 being N or C,T1 represents -CH2-CH2-, -CH=CH- or =CH-CH2-, and T2 is a bond, or T1 represents -CH2- or =CH- and T2 is -CH2-, =CH-,R5 represents -(CH2)m-COOR6,R6 and R6' represent hydrogen, alkyl, optionally substituted aryl or optionally substituted arylalkyl,A represents -CO-, -CH2-, =CH- or -CH= and W represents -CH-, =C- or -C=, or A represents -CO- or -CH2- and W represents N,X represents -CO-X1-, -CO-NR6-X1-, -NR6-CO-X1-, -O-X1-, -SO2-NR6-X1- or -S(O)n-X1-,Y represents -Y1-, -Y2-Y1- or -Y1-Y2-Y1-, Y1 being an alkylene, alkenylene or alkynylene, and Y2 being an arylene, heteroarylene, cycloalkylene or heterocycloalkylene,Z represents -Z1-, -Z10-NR6-, and -Z10-NR6-CO-, Z1 being a heteroaryl, heterocycloalkyl, heteroarylalkyl, heterocycloalkylalkyl, fused arylheteroaryl, fused arylheterocycloalkyl, fused heteroarylheterocycloalkyl, fused heterocycloalkylheteroaryl or fused heteroarylheteroaryl, each of which is optionally substituted, or a group,Z2-NR6 or Z2-NR6-CO, Z2 being a group Z1, alkyl or heteroalkyl, andZ10 represents Z1 or an alkyl,its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base,and medicinal products containing the same which are useful as vitronectin receptor antagonists.
-
公开(公告)号:AU750691B2
公开(公告)日:2002-07-25
申请号:AU4346699
申请日:1999-08-10
Applicant: SERVIER LAB
Inventor: HANESSIAN STEPHEN , ATASSI GHANEM , TUCKER GORDON , CAIGNARD DANIEL-HENRI , RENARD PIERRE
IPC: C12N9/99 , A61K31/18 , A61K31/185 , A61K31/35 , A61K31/351 , A61K31/4406 , A61K31/4418 , A61K31/445 , A61P43/00 , C07C319/14 , C07C319/20 , C07C323/60 , C07D211/20 , C07D213/34 , C07D309/04 , C07D213/56 , C07D309/32 , C07C323/67
Abstract: Hydroxamic acid derivatives (I) are new. Hydroxamic acid derivatives of formula (I) and their acid and base addition salts are new. R1 = 1-6C alkyl (optionally substituted by at least one OH, halo, 1-6C alkoxy, mercapto, 1-6C alkylthio, aryl, 1-6C acyl or amino (optionally substituted by one or two 1-6C alkyl, cycloalkyl or aryl)), 1-6C acyl, cycloalkyl, aryl, heterocyclic group or aminocarbonyl-1-6C alkyl (with amino optionally substituted by one 1-6C alkyl (optionally substituted by at least one aryl, 1-6C arylalkyl, cycloalkyl or 1-6C alkylaminocarbonyl; R2 = 1-4C alkylene; R3 = X or T-U'-V'- X = 1-6C alkyl, 1-6C acyl, 1-6C alkoxycarbonyl, 1-6C aminoalkyl (amino optionally substituted by one or two 1-6C alkyl), 1-6C hydroxyalkyl, 1-6C carboxyalkyl, 1-6C aminocarbonylalkyl, 1-6C mercaptoalkyl, cycloalkyl, aryl or heterocyclic; T = aryl or heterocyclic; U' = single bond, S, O, NH, carbonyl, -R8O-, -R8S-, -R8NH-, -R8OR9-, -R8-NH-R9-, -R8-CO-R9- or -R9- (with R8 bound to T and R9 bound to V'); R8 = 1-6C alkylene; R9 = arylene or heteroarylene; V' = 1-6C alkylene; R4 = biaryl, arylheteroaryl, heteroarylaryl, 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic; and provided that R4 is 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic, when R3 is T-U'-V'-. An Independent claim is also included for the preparation of (I).
-
60.
公开(公告)号:AU1193702A
公开(公告)日:2002-07-25
申请号:AU1193702
申请日:2002-01-18
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , GUILBAUD NICOLAS , TUCKER GORDON , PIERRE ALAIN , HICKMAN JOHN , DOREY GILBERT , DIGUARHER THIERRY LE
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07D213/74 , A61K31/41
Abstract: Compound of formula (I):wherein:X represents a bond or alkylene, CO, S(O)n, -S(O)n-A1-, -CO-A1-, -A-S(O)n-A'1- or -A1-CO-A'1-,Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted,or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle,T represents -CH(R5)-, -N(R5)- or -N(R5)CO-,V represents hydrogen or unsubstituted or substituted aryl or heteroaryl,A2 represents [C(R6)(R'6)]p,R7 and R8 are as defined in the description,their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
-
-
-
-
-
-
-
-
-